μ3 Opiate receptor expression in lung and lung carcinoma: Ligand binding and coupling to nitric oxide release

Cancer Letters

Volumn 146, Issue 1, 1999, Pages 45-51

  Fimiani, C ^a,b   Arcuri, E ^c   Santoni, A ^b   Rialas, C M ^a   Bilfinger, T V ^d   Peter, D ^a   Salzet, B ^e   Stefano, G B ^a,d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d STONY BROOK UNIVERSITY   (United States)

^e Centre de Biologie Cellulaire   (France)

Author keywords

3; Alternative splicing; Cancer; Lung; Morphine; Neoplasia; Nitric oxide; Opioid receptor transcript

Indexed keywords

MORPHINE; MU OPIATE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; DIHYDROMORPHINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; LUNG CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SOUTHERN BLOTTING; BIOSYNTHESIS; CHEMISTRY; GENETICS; LUNG; LUNG TUMOR; METABOLISM;

DIHYDROMORPHINE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HUMANS; LUNG; LUNG NEOPLASMS; NITRIC OXIDE; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

EID: 0032585763     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00227-X     Document Type: Article

References (27)

1. deRojas-Walker T., Tamir S., Ji H., Wishnok J.S., Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol. 8:1995;473-477.
2. Xiao L., Eneroth P.H.E., Qureshi G. Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand. J. Immunol. 42:1995;505-511.
3. Mordan L.J., Brunett T.S., Zhang L.X., Tom J., Cooney R.V. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis. 14:1993;1555-1559.
4. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 19:1998;711-721.
5. Maneckjee R., Minna J.D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. USA. 87:1990;3294-3298.
6. Abou-Issa H., Tejwani G.A. Antitumor activity of naltrexone and correlation with steroid hormone receptors. Biochem. Biophys. Res. Commun. 175:1991;625-630.
7. Schreiber G., Campa M.J., Prabhakar S., O'Briant K., Bepler G., Patz E.F. Jr. Molecular characterization of the human delta opioid receptor in lung cancer. Anticancer Res. 18:1998;1782-1792.
8. Stefano G.B., Digenis A., Spector S., Leung M.K., Bilfinger T.V., Makman M.H., Scharrer B., Abumrad N.N. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA. 90:1993;11099-11103.
9. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A., Fricchione G.L. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
10. Makman M.H., Bilfinger T.V., Stefano G.B. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154:1995;1323-1330.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
12. Bare L.A., Mansson E., Yang D. Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354:1994;213-216.
13. Chuang T.K., Killam K.F. Jr, Chuang L.F., Kung H.F., Sheng W.S., Chao C.C., Yu L., Chuang R.Y. Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun. 216:1995;922-930.
14. Stefano G.B., Melchiorri P., Negri L., Hughes T.K., Scharrer B. [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc. Natl. Acad. Sci. USA. 89:1992;9316-9320.
15. Stefano G., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., Goligorsky M.S. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270:1995;30290-30293.
16. Stefano G.B., Christensen V.B., Tonnesen E., Liu Y., Hughes T.K., Bilfinger T.V. Interleukin-10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J. Cardiovasc. Pharmacol. 30:1997;90-95.
17. Magazine H.I., Liu Y., Bilfinger T.V., Fricchione G.L., Stefano G.B. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol. 156:1996;4845-4850.
18. Elliott J., Smart D., Lambert D.G., Traynor J.R. Characterization of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine. Eur. J. Pharmacol. 16:1994;447-450.
19. Ambs S., Bennett W.P., Merriam W.G., Ogunfusika M.O., Oser S.M., Khan M.A., Jones R.T., Harris C.C. Vasuclar endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. Br. J. Cancer. 78:1998;233-239.
20. Lysle D.T., How T. Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes. J. Pharmacol. Exp. Ther. 288:1999;502-508.
21. Nicotera P., Bonfoco E., Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv. Neuroimmunol. 5:1995;411-420.
22. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xi W.Q.W., Nathan C., Fidler T.R. with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181:1995;1333-1343.
23. Kong L., Dunn G.D., Keefer L.K., Korthuis R.J. Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin. Exp. Metastasis. 14:1996;335-343.
24. Bilfinger T.V., Hartman A., Liu Y., Magazine H.I., Stefano G.B. Cryopreserved veins in myocardial revascularization: possible mechanism for their increased failure. Ann. Thorac. Surg. 63:1997;1063-1069.
25. Lejeune P., Lagadec C.P., Onier N., Pinard D., Ohshima H., Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol. 152:1994;5077-5083.
26. Rossi G.C., Pan Y.X., Brown G.P., Pasternak G.W. Antisense mapping of the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. FEBS Lett. 369:1995;192-196.
27. Mayer P., Schulzeck S., Draus J., Zimprich A., Hollt V. Promoter region and alternatively spliced exons of the rat mu-opioid receptor gene. J. Neurochem. 66:1996;2272-2278.